What is Happening?
IRB review fees are being increased on July 1st, 2021. This applies to studies that are industry-sponsored and studies from UCSF-affiliated entities.
Why Must Fees Be Increased at This Time?
The IRB’s current fee structure has fallen far behind a fair assessment for the increasing effort and operating costs of IRB reviews. Since the last fee adjustment in 2013, IRB submission volume has increased, as have the costs of running the office.
What Types of Studies are Subject to IRB Review Fees?
- Studies funded by private industry
- Studies submitted on behalf of UCSF-affiliated institutions. This includes the following entities: NCIRE, Gladstone Institutes, Institute on Aging, SF Coordinating Center, Vitalant and the Vitalant Research Institute, SFDPH, ZSFG, and SFVAHCS.
What Types of IRB Submissions are Affected by the New Fee Structure?
IRB review fees will increase for the following types of reviews:
- New studies (Full Committee and Expedited)
- Continuing reviews (Full Committee and Expedited)
- Requests to rely on an external IRB
Additionally, the IRB will begin charging a modest fee for review of the following:
- Modifications
- Personnel changes
- Enrollment exception requests
The new fees are listed in this document “IRB FY22 Updated Fees.” This document also provides a more detailed explanation about why the fees are being increased, including data on work volume and operating costs.
The new rates will be in effect for submissions on or after July 1, 2021.
If you have questions, please contact us via the Ask Andy form (preferred), email ([email protected]), or phone (415-476-1814).